China has witnessed rapid development in the field of Fluorescence Immunochromatography (FIA) Point-of-Care Testing (POCT), emerging as a hub for high-quality suppliers with leading technologies and global reach. These enterprises leverage independent R&D capabilities, comprehensive product portfolios, and efficient market responsiveness to meet the rapid testing needs of domestic medical, food, animal husbandry and other sectors. They also actively expand into international markets, becoming a crucial force in the global FIA POCT industry. Below are introductions to 10 core FIA POCT suppliers in China, ranked by comprehensive strength and industry influence.
1. Innochek Biotech Co., Limited
INNOCHEK BIOTECH CO., LTD, are dedicating in delivering comprehensive, efficient, and innovative POCT solutions to global users. The company was stablished in 2017 and headquartered in Hongkong, is a conglomerate seamlessly integrating R&D, production, registration, sales, and marketing. Leveraging microfluidics and electrochemical technologies, INNOCHEK has successfully developed a diverse range of key products, including blood gas and electrolytes, immunofluorescence, coagulation, and animal diagnostic series.
Our technology development platform includes dry blood gas, electrolyte, microfluidic dry biochemistry, dry coagulation, and liquid phase fluorescence immunoassay platforms.
2. Wondfo Biotech Co., Ltd. (Guangzhou)
A leading enterprise in China's POCT industry, its business covers infectious disease testing, chronic disease testing, prenatal and postnatal care and other fields. Fluorescence immunoassay technology is its core advantage, and products are exported to many countries and regions around the world.
3. InnoTest Biotech Co., Ltd. (Beijing)
Founded in 2006, it focuses on respiratory tract testing, while covering digestive tract, hepatitis and other scenarios. It has 6 major technology platforms including fluorescence immunoassay, holds more than 100 domestic and foreign medical device registration certificates, and cooperates with over 2,000 terminal hospitals.
4. Fosun Diagnostics (Shanghai) Co., Ltd.
Established in 2014, it specializes in food safety and animal disease testing. It independently developed the fluorescence quantitative FPOCT technology platform, with products covering mycotoxins, pesticide residues, animal epidemics and other series. It has formed strategic cooperation with large enterprises such as China Grain Reserves Group and Uni-President Group.
5. Sansure Biotech Inc.
With molecular diagnostic technology as the core, its FIA POCT products focus on infectious disease testing, featuring rapid screening and accurate quantification. It has played an important role in responding to global public health incidents, with a continuously expanding international market share.
6. Getein Biotech, Inc.
Dedicated to the R&D of in vitro diagnostic reagents and medical devices, its FIA POCT products cover testing fields such as cardiovascular diseases, inflammation and kidney injury. With high cost-effectiveness and stable performance, they are widely used in medical institutions at all levels.
7. Mindray Bio-Medical Electronics Co., Ltd. (Wuhan)
Focusing on acute and critical care fields, its FIA POCT products include test kits for infectious diseases, cardiovascular and cerebrovascular diseases, etc. It has gained market recognition for rapid response and accurate results.
8. Shenzhen YHLO Biotech Co., Ltd.
Its business covers testing of autoimmune diseases, infectious diseases, etc. Its fluorescence immunoassay products have mature technologies, and it also expands into overseas markets, gradually establishing a global marketing network.
9. Sinocare Inc.
With blood glucose testing as the core, it has expanded into multi-field FIA POCT products. With a product positioning of convenience and home use, it has become an important supplier in the primary medical care and home testing markets.
10. Hybribio Biotech Co., Ltd. (Guangdong)
Focusing on the combination of nucleic acid testing and fluorescence immunoassay technology, its FIA POCT products have advantages in infectious diseases, prenatal and postnatal care and other fields, with cooperative institutions across national medical systems at all levels.